Dr Reddy's Laboratories receives tentative approval for Zenavod (doxycycline) Capsules

From US FDA

Dr Reddy's Laboratories announced that the United States Food and Drug Adminstration tentative approval for Zenavod (doxycycline) Capsules, 40 mg. Zenavod is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. Promius Pharma, LLC, the US subsidiary of Dr Reddy's Laboratories will be responsible for commercialising Zenavod in the US market.

Powered by Capital Market - Live News